These aggressive prostate cancers fuse the promoter of TMPRSS2, an androgen responsive gene, to an ETS family transcription factor, such as ETV1 or ERG[29], both of which have also been identified in joining to EWS in ESFT to form an oncogenic fusion protein [30-32]. Here, ERG is linked to prostate cancer.